# OnCo record gagome-mced-test (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/gagome-mced-test/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "gagome-mced-test" ;
  schema:name "Elypta GAGome multi-cancer test"@en ;
  schema:alternateName "GAGome test"@en, "free GAGome MCED test"@en, "MIRAM GAGome"@en, "GAGome" ;
  schema:description "A test in development from Elypta in Sweden that reads sugar molecules in urine and blood rather than DNA, aiming to flag many cancers including some that DNA tests find hard to see."@en ;
  schema:url <https://onco.cc/drugs/gagome-mced-test/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://doi.org/10.1073/pnas.2115328119>, <https://www.elypta.com/news/elypta-interim-study-results-show-glycosaminoglycan-potential-to-predict-the-risk-of-developing-any-type-cancer-with-a-simple-urine-test> ;
  onco:status "emerging" ;
  onco:tag "test", "mced", "evidence:insufficient" ;
  onco:modality "Multi-cancer early detection test in development (urine and plasma glycosaminoglycans)" ;
  onco:technologies <https://onco.cc/technologies/mced/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:companies <https://onco.cc/companies/elypta/> ;
  onco:trials <https://onco.cc/trials/lev87a/>, <https://onco.cc/trials/lev93a/>, <https://onco.cc/trials/vincere-firefighters-mced/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-bratulic-gagome-pnas-2022/> .